BridgeMD
Compares treatment options for Colorectal Cancer Screening
Official title Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
ClinicalTrials.gov ID: NCT06666556
What this study is testing
What is Bowel preparation before colonoscopy?
Bowel preparation before colonoscopy is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for colorectal cancer screening.
Also referred to as Lactulose.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial it is to bowel the instestinal preparation with lactulose vs poliethylenglicol as better agent to have a quality colonoscopy and demostrate that lactulose is most efective, has a good tolerance and the patient would have a better satisfaction, so the question is: wich is the eficancy of lactulose in comparision with thepoliethylenglycol in the intestinal preparation for the colonoscopy?
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 79. Healthy volunteers may be eligible.
You may be able to join if
- Patients with indication for colonoscopy in our coloproctology service
- Both women and men
- Patients within an age range of 18-79 years
- Patients who agree having a colonoscopy and who sign the informed consent to participate in the protocol
You likely can't join if
- Patients under 18 or over 80 years old
- All patients that won´t like to participate in the protocol or won´t sign the informed consent
- Pregnant women
- Patients with a medical record of colonic resection, ostomy status, severe cardiopulmonary and renal diseases, major psychiatric disorders...
- Non compliance with the colonic preparation regimen
- Active bleeding during the procedure
See the full eligibility criteria
- Patients with indication for colonoscopy in our coloproctology service
- Both women and men
- Patients within an age range of 18-79 years
- Patients who agree having a colonoscopy and who sign the informed consent to participate in the protocol
- Patients under 18 or over 80 years old
- All patients that won´t like to participate in the protocol or won´t sign the informed consent
- Pregnant women
- Patients with a medical record of colonic resection, ostomy status, severe cardiopulmonary and renal diseases, major psychiatric disorders, therapeutic colonoscopy or any contraindications for colonoscopy
- Non compliance with the colonic preparation regimen
- Active bleeding during the procedure
- Patients with a known diagnosis of colorectal cancer
The study team makes the final eligibility decision.
Where it's taking place
- Guadalajara, Jalisco, Mexico
- México, Toluca de Lerdo, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 79 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guadalajara, Jalisco, Mexico; México, Toluca de Lerdo, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.